Warning about insulin pump failure 18 August 2025 Users of the t:slim X2 insulin pump are being made aware of a malfunction that could stop the device from working. The Therapeutic Goods Administration (TGA) has issued a warning that certain versions of the insulin pump have a wiring problem with the speaker that could stop the delivery of insulin. Australasian Medical and Scientific Ltd (AMSL) alerted the TGA to the failure which appears on device screens as Malfunction Code 16-0x20E6, or simply ‘Malfunction 16’. ARTG numberCatalogue numberMultiple serial numbers30468110027175317 unique serial numbers identified in Australia What are the risks? The problem could: Stop insulin delivery and disconnect the pump from the Continuous Glucose Monitoring (CGM) and mobile app. Lead to hyperglycaemia if not addressed promptly. Require patients to seek medical intervention or hospitalisation in serious cases. Result in loss of real-time glucose data and trends. What should I do? If Malfunction 16 has not occurred: Continue using your pump as per the user guide. Install the Tandem t:slim mobile app and enable push notifications. This ensures that if the problem does occur, you will be notified by the app. If using a Dexcom sensor, use the Dexcom mobile app as a backup source for CGM alerts and alarms. If a Malfunction 16 occurs: Acknowledge the alert by pressing “Silence Alarm.” Contact AMSL Technical Support at 1300 851 056, who will arrange for a replacement pump. In the meantime, switch to your backup insulin delivery method. You should continue to monitor your blood glucose levels regularly and ensure a backup insulin method is available as per the pump training and user guide. Further information Please contact AMSL on 1300 851 056 for further information. A software update is in development that will improve early detection of speaker failure and introduce persistent vibration alerts. Pump users will be notified when this software update becomes available. Reporting problems Consumers and health professionals are encouraged to report problems with medical devices. Your report will contribute to our monitoring of these products. For more information see the TGA Incident Reporting and Investigation Scheme (IRIS). The TGA cannot give advice about an individual’s medical condition. You are strongly encouraged to talk with a health professional if you are concerned about a possible adverse event associated with a medical device.
Media releases 14 August 2026 Beyond blood glucose: New national partnership to measure how Australians with diabetes are really doing For the first time, the Australian Unity Wellbeing Index will be used to build the most complete picture yet of how diabetes affects Australian’s lives beyond clinical outcomes and health system costs, thanks to a partnership between Diabetes Australia, Deakin University, and the Australian Unity Support Foundation. Continue Reading
Media releases 13 August 2026 PMOS in spotlight for diabetes prevention A new partnership between Diabetes Australia and the Medibank Better Health Research Hub will support Monash University to develop a primary care model to better detect and prevent type 2 diabetes in women living with polyendocrine metabolic ovarian syndrome (PMOS). Continue Reading
News 7 August 2026 Brett Fenton appointed Adjunct Clinical Fellow at UTS Diabetes Australia warmly welcomes Chief Health Officer Brett Fenton's appointment as an Adjunct Clinical Fellow at the University of Technology Sydney (UTS). Continue Reading